Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials
Authors
Keywords
-
Journal
JOURNAL OF BIOSCIENCES
Volume 45, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-12
DOI
10.1007/s12038-020-00053-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
- (2020) Philippe Colson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): Facts and myths
- (2020) Chih-Cheng Lai et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Return of the Coronavirus: 2019-nCoV
- (2020) Lisa E. Gralinski et al. Viruses-Basel
- Infection and Rapid Transmission of SARS-CoV-2 in Ferrets
- (2020) Young-Il Kim et al. Cell Host & Microbe
- Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
- (2020) Jasper Fuk-Woo Chan et al. CLINICAL INFECTIOUS DISEASES
- The many estimates of the COVID-19 case fatality rate
- (2020) Dimple D Rajgor et al. LANCET INFECTIOUS DISEASES
- Labs rush to study coronavirus in transgenic animals — some are in short supply
- (2020) Ewen Callaway NATURE
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China
- (2020) Joseph T. Wu et al. NATURE MEDICINE
- Facing Covid-19 in Italy — Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line
- (2020) Lisa Rosenbaum NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
- (2020) Cynthia Liu et al. ACS Central Science
- Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS
- (2020) Kaihao Liang INFECTION GENETICS AND EVOLUTION
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
- (2018) Mario Mauthe et al. Autophagy
- Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody
- (2017) Katherine V. Houser et al. PLoS Pathogens
- History of highly pathogenic avian influenza
- (2016) D.J. ALEXANDER et al. REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
- Ferret models of viral pathogenesis
- (2015) T. Enkirch et al. VIROLOGY
- Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model
- (2012) Mark J. Cameron et al. PLoS One
- Accelerating vaccine development and deployment: report of a Royal Society satellite meeting
- (2011) M. Bregu et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Vaccine-induced enhancement of viral infections
- (2008) W. Huisman et al. VACCINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started